We are pleased to announce that the Joint "Rapid relative effectiveness assessment of new pharmaceuticals for the treatment of chronic Hepatitis C" og WP5-SA6 is now available.

This joint rapid assessment of WP5 Strand A evaluates multiple new pharmaceuticals for the treatment of Chronic Hepatitis C.

Find the joint assessment here.